The shortages of Novo Nordisk’s Ozempic and Wegovy, a Type 2 diabetes and weight loss drug, respectively, could continue for years, Forbes reported Sept. 16.
Read the full post on Becker's Hospital Review - Healthcare News
Ozempic, Wegovy shortages could last years
